132 related articles for article (PubMed ID: 178047)
1. Transfer factor treatment of patients with multuple sclerosis. I. Preliminary report of changes in immunological parameters.
Jersild C; Platz P; Thomsen M; Dupont B; Svejgaard A; Ciongoli AK; Fog T; Grob P
Scand J Immunol; 1976; 5(1-2):141-8. PubMed ID: 178047
[TBL] [Abstract][Full Text] [Related]
2. Long-term transfer-factor treatment for multiple sclerosis.
Fog T; Pedersen L; Raun NE; Kam-Hansen S; Mellerup E; Platz P; Ryder LP; Jakobsen BK; Grob P
Lancet; 1978 Apr; 1(8069):851-3. PubMed ID: 76798
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated immunity to viral antigens and tuberculin in multiple sclerosis.
Sagar HJ; Allonby ID; Hughes P
Acta Neurol Scand; 1981 Feb; 63(2):81-98. PubMed ID: 6259870
[TBL] [Abstract][Full Text] [Related]
4. Cell mediated immunity to viral antigens in multiple sclerosis.
Zabriskie JB; Espinoza LR; Plank CR; Collins RC
Acta Neurol Scand Suppl; 1977; 63():239-51. PubMed ID: 265669
[No Abstract] [Full Text] [Related]
5. Viral antibodies in multiple sclerosis.
Norrby E
Prog Med Virol; 1978; 24():1-39. PubMed ID: 704893
[No Abstract] [Full Text] [Related]
6. Mixed lymphocyte culture determinants, measles infection and multiple sclerosis.
Platz P; Dupont B; Fog T; Ryder L; Thomsen M; Svejgaard A; Jersild C
Proc R Soc Med; 1974 Nov; 67(11):1133-6. PubMed ID: 4140520
[No Abstract] [Full Text] [Related]
7. Cell-mediated immunity in multiple sclerosis.
Espinoza LR; Ebers G; Mountcastle W; Zabriskie JB
Acta Neurol Scand Suppl; 1977; 63():123-31. PubMed ID: 265663
[TBL] [Abstract][Full Text] [Related]
8. A double-blind trial of transfer factor vs placebo in multiple sclerosis patients.
Collins RC; Espinoza LR; Plank CR; Ebers GC; Rosenberg RA; Zabriskie JB
Clin Exp Immunol; 1978 Jul; 33(1):1-11. PubMed ID: 361313
[TBL] [Abstract][Full Text] [Related]
9. Cell-mediated immunity to measles virus in multiple sclerosis: correlation with disability.
Symington GR; Mackay IR
Neurology; 1978 Feb; 28(2):109-12. PubMed ID: 202889
[TBL] [Abstract][Full Text] [Related]
10. Letter: Suppressed cellular immunity to measles antigen in multiple-sclerosis patients.
Utermohlen V; Zabriskie JB
Lancet; 1973 Nov; 2(7838):1147-8. PubMed ID: 4128034
[No Abstract] [Full Text] [Related]
11. The HLA system and multiple sclerosis.
Jersild C
Birth Defects Orig Artic Ser; 1978; 14(5):123-70. PubMed ID: 99191
[No Abstract] [Full Text] [Related]
12. Measles-adherent lymphocyte phenomenon of Levy in multiple sclerosis: normal reactivity of blood lymphocytes.
Kinnman J; Link H
Acta Neurol Scand; 1979 May; 59(5):241-7. PubMed ID: 314219
[TBL] [Abstract][Full Text] [Related]
13. Influence of measles virus antigen on leukocyte migration in multiple sclerosis and controls.
Kinnman J; Link H; Möller E; Norrby E
Acta Neurol Scand; 1978 Nov; 58(5):261-71. PubMed ID: 216219
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte stimulation in multiple sclerosis patients untreated and treated with transfer factor. Long-term studies on the effect of different stimulants on myo-(2-3H)inositol incorporation into phosphatidylinositol of lymphocytes.
Offner H; Raun NE; Konat G; Fog T; Clausen J
Acta Neurol Scand; 1977 Dec; 56(6):465-74. PubMed ID: 605771
[TBL] [Abstract][Full Text] [Related]
15. Transfer factor in treatment of multiple sclerosis.
Basten A; McLeod JG; Pollard JD; Walsh JC; Stewart GJ; Garrick R; Frith JA; Van Der Brink CM
Lancet; 1980 Nov; 2(8201):931-4. PubMed ID: 6107585
[TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis: cellular and humoral immune responses to several viruses.
Fuccillo DA; Madden DL; Castellano GA; Uhlig L; Traub RG; Mattson J; Krezlewicz A; Sever JL
Neurology; 1978 Jun; 28(6):613-5. PubMed ID: 206860
[TBL] [Abstract][Full Text] [Related]
17. [Current data on the etiopathogenesis of multiple sclerosis].
Verdeş F
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1977; 22(3):189-99. PubMed ID: 337441
[No Abstract] [Full Text] [Related]
18. Studies on the immune response in multiple sclerosis and other inflammatory diseases of the central nervous system.
Kinnman J
Acta Neurol Scand Suppl; 1981; 81():1-96. PubMed ID: 6939210
[No Abstract] [Full Text] [Related]
19. The use of transfer factors in the treatment of multiple sclerosis: a case report.
Sacks N; Potgieter HJ; Van Rensburg AJ
S Afr Med J; 1976 Sep; 50(40):1556-8. PubMed ID: 982209
[TBL] [Abstract][Full Text] [Related]
20. [Measles cellular immunity in patients with multiple sclerosis].
Atanadze SN; Kodkind GKh; Smirnov YuK ; Khomak VIa; Veĭn AM
Vopr Virusol; 1980; (2):166-9. PubMed ID: 6992452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
